From: An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours)
Group
Number of cases
Number of events
Number censored
Mean survival time in days (95% C.I)
AS/SMP
229
13
216(94.3%)
27.541 (27.249-27.834)
AS/AQ
238
4
234(98.3%)
27.882 (27.695-28.070)